Skip to main content
OpenTrials
Completed

NCT Number: NCT03208894

Role of Salbutamol and Furosemide in TTN

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Transient Tachypnea of the Newborn Congenital, Hereditary, and Neonatal Diseases and Abnormalities Infant, Newborn, Diseases Infant, Premature, Diseases Lung Diseases Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory Tachypnea

Age range

1 hour–7 day

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Department of Pediatrics, Rawalpindi, Punjab Province, Pakistan

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all newborn babies with clinically diagnosed TTN

Exclusion criteria

  • babies less than 34 weeks babies with congenital malformations and CHD

Treatment and study plan

Furosemide Injection

Drug

efficacy of salbutamol and furosemide in TTN

Other names: salbutamol inhalation

Primary outcomes

  1. duration of oxygen requiremment in neonates having TTN.

    Time frame: upto 6 months

    neonates will be subjected to treatment with furosemide and sabutamol and the duration of oxygen dependecy will be assessed.

Sponsors and collaborators

Lead sponsor

Armed Forces Hospital, Pakistan

Other

Registry information

Official study title

Role of Salbutamol and Furosemide in Transient Tachypnea of Newborn

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jul 6, 2017
Registry last updated
Jul 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.